4//SEC Filing
NPS PHARMACEUTICALS INC 4
Accession 0001104659-15-013585
CIK 0000890465operating
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 9:16 PM ET
Size
17.3 KB
Accession
0001104659-15-013585
Insider Transaction Report
Form 4
Graf Susan E
VP of Corp Dev & Strategy
Transactions
- Disposition to Issuer
Restricted Stock Units
2015-02-21−2,893→ 0 total→ Common Stock (2,893 underlying) - Disposition from Tender
Common Stock
2015-02-21$46.00/sh−4,761$219,006→ 0 total - Disposition to Issuer
Stock Options (right to buy)
2015-02-21−41,289→ 0 totalExercise: $14.90Exp: 2023-06-17→ Common Stock (41,289 underlying) - Disposition to Issuer
Stock Options (right to buy)
2015-02-21−11,874→ 0 totalExercise: $38.27Exp: 2024-02-12→ Common Stock (11,874 underlying) - Disposition to Issuer
Restricted Stock Units
2015-02-21−10,905→ 0 total→ Common Stock (10,905 underlying) - Disposition to Issuer
Restricted Stock Units
2015-02-21−11,577→ 0 total→ Common Stock (11,577 underlying)
Footnotes (8)
- [F1]In connection with the merger of Knight Newco 2, Inc. with and into NPS Pharmaceuticals, Inc. (the "Issuer") on February 21, 2015, each outstanding stock option, whether vested or unvested, was cancelled in exchange for a single lump sum cash payment in an amount equal to the product of (1) the number of shares of the Issuer's common stock subject to such stock option and (2) the execess, if any, of $46.00 over the exercise price per share of such stock option.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]On February 12, 2015, the Restricted Stock Units were granted with (i) one third vesting on the first anniversary of date of grant, (ii) one third on the second anniversary of date of grant and (iii) one third on the third anniversary of date of grant.
- [F4]In connection with the merger of Knight Newco 2, Inc. with and into the Issuer on February 21, 2015, each outstanding Restricted Stock Unit was cancelled in exchange for a lump sum cash payment in an amount equal to the product of (1) $46.00 and (2) the number of shares of common stock subject to such Restricted Stock Unit.
- [F5]On February 12, 2014, the Restricted Stock Units were granted with (i) one third vesting on the first anniversary of date of grant, (ii) one third on the second anniverary of date of grant and (iii) one third on the third anniverary of date of grant.
- [F6]On June 17, 2013, the Restricted Stock Units were granted with (i) one third vesting on the first anniversary of date of grant, (ii) one third on the second anniverary of date of grant and (iii) one third on the third anniverary of date of grant.
- [F7]On June 17, 2013, the stock options were granted with one fourth vesting on the first anniversary of date of grant and 6.25% vesting every three months thereafter.
- [F8]On February 12, 2014, the stock options were granted with one fourth vesting on the first anniversary of date of grant and 6.25% vesting every three months thereafter.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000890465
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 9:16 PM ET
- Size
- 17.3 KB